Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group

A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK).

ESMO open·2025

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey.

ESMO open·2023

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.

British journal of cancer·2023

The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective.

ESMO open·2021

Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies.

ESMO open·2021

The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer.

European journal of cancer & clinical oncology·1989

Nutritional factors and cancers of the breast, endometrium and ovary.

European journal of cancer & clinical oncology·1989

Reproductive factors and cancers of the breast, ovary and endometrium.

European journal of cancer & clinical oncology·1989

Multiple primary cancers of the breast, endometrium and ovary.

European journal of cancer & clinical oncology·1989

Cancers of the breast, endometrium and ovary: geographic correlations.

European journal of cancer & clinical oncology·1989

Hormone replacement therapy in women treated for breast cancer.

European journal of cancer & clinical oncology·1989

Development and implementation of a standardized audit tool for cytotoxic drug preparation practices in oncology.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Gaps in Onco-Cardiology Practice and Educational Needs for the Next Generation of Pharmacists in Japan.

Circulation reports·2026

PET imaging enables direct evaluation of ferroptosis in HCC synergistically induced by anti-PD-L1 and Olaparib.

Experimental & molecular medicine·2026

Fusobacterium nucleatum mediated crosstalk drives cisplatin resistance in head and neck cancer.

Oncology·2026

Guiding Risk Reduction for Breast Cancer-Relevant Chemicals (BC-Chems): Chemical Production Volumes, Sources, Intake Levels, Emissions, and Regulations.

Environmental health perspectives·2026

Integrated network toxicology and multi-omics profiling reveal cell cycle, DNA damage repair, and metabolic alterations in cyclophosphamide-induced premature ovarian insufficiency.

Frontiers in pharmacology·2026

Related Experiment Videos

Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group

Related Concept Videos

A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK).

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey.

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.

The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective.

Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies.

The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer.

Nutritional factors and cancers of the breast, endometrium and ovary.

Reproductive factors and cancers of the breast, ovary and endometrium.

Multiple primary cancers of the breast, endometrium and ovary.

Cancers of the breast, endometrium and ovary: geographic correlations.

Hormone replacement therapy in women treated for breast cancer.

Development and implementation of a standardized audit tool for cytotoxic drug preparation practices in oncology.

Gaps in Onco-Cardiology Practice and Educational Needs for the Next Generation of Pharmacists in Japan.

PET imaging enables direct evaluation of ferroptosis in HCC synergistically induced by anti-PD-L1 and Olaparib.

Fusobacterium nucleatum mediated crosstalk drives cisplatin resistance in head and neck cancer.

Guiding Risk Reduction for Breast Cancer-Relevant Chemicals (BC-Chems): Chemical Production Volumes, Sources, Intake Levels, Emissions, and Regulations.

Integrated network toxicology and multi-omics profiling reveal cell cycle, DNA damage repair, and metabolic alterations in cyclophosphamide-induced premature ovarian insufficiency.

Related Experiment Videos

Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group

Related Concept Videos

Related Articles